News

Trump wants to cut out ‘middleman’ as part of drug pricing order: What are pharmacy benefit managers?
President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit ...
Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna
Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Septerna (SEPN) for obesity pills — the ...
Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Sapterna
Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.